24th Jun 2025 Plain language summary: two key studies on acalabrutinib’s efficacy and safety profile for treating patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma
13th Mar 2025 A plain language summary of the ELEVATE-TN study: Chemotherapy-free treatment with acalabrutinib for previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma
